| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |